RHY 1.64% 6.0¢ rhythm biosciences limited

Bescreened 10,000 patient tests /trial, page-16

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    I located the full Bescreened report that your charts below are taken from. It details the results of their little clinical trial of 110 people, 45 of whom were known to already have CRC.

    The report lists the 3 bio markers they use, surprisingly one of them is CEA. CEA is a widely used blood biomarker used to check how cancer patients are responding to treatment, or for relapse. CEA does not differentiate between different cancer types, it's a general tumour marker. It's not recommended for use as a screening test because it's not considered reliable for that purpose.

    The last graph is interesting, it appears to show that Bescreened were able to positively identify all 45 patients in their study who were known to already have CRC... using CEA which tests for cancer generally.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.001(1.64%)
Mkt cap ! $14.91M
Open High Low Value Volume
6.1¢ 6.2¢ 6.0¢ $7.244K 119.2K

Buyers (Bids)

No. Vol. Price($)
1 54512 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 144742 1
View Market Depth
Last trade - 15.39pm 09/07/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.